News

Latest news

Hide mandatory notifications of trade

Capital Markets Day 14 June

Click for information and registration

 

Bionor Pharma invites to Capital Markets Day at hotel Continental Friday 14 June at 10:00


Press release about the Capital Markets Day

For detailed program, click here

For registration, click here or send an e-mail to post@bionorpharma.com


Prof. Lars Østergaard will be presenting at Bionor Pharma’s Capital Markets Day.

Lars Østergaard, chief physician, MD, PhD, DMSc, is professor of infectious diseases, University of Aarhus, and Head of Dept. of Infectious Diseases, Aarhus University Hospital, Denmark. Dr. Østergaard has been principal investigator in several research projects with up to 50 active researchers and administrative workers. He has been responsible for more than 200 papers in peer reviewed scientific journals and filed 8 patent applications, and is reviewer for the Lancet, British Medical Journal, Journal of Infectious Diseases, AIDS, and Clinical Infectious Diseases. Lars Østergaard has a small stock position in Bionor Pharma, and he has joined Bionor Pharma’s Clinical Advisory Board (CAB).

Article about the HIV research from Aarhus University Hospital on their website:
http://www.en.auh.dk/news+and+media/news+archive/shownews?showNews=126096

Article in The Telegraph April 2013 about the novel HIV research by Dr. Østergaard and his team:

http://www.telegraph.co.uk/health/healthnews/10022664/Scientists-hope-for-HIV-cure.html

The same research has also been featured in Dagbladet in May:

http://www.dagbladet.no/2013/05/03/nyheter/utenriks/forskning/helse/hiv/26989914/